[WOMEN'S CARDIAC HEALTH - FROM THEORY TO ACTIVISM]

Avital Porter1

  • 1Cardiology Unit (intermediate) and the Women's Heart Clinic, Rabin Medical Center - Beilinson and Tel Aviv University.

Harefuah
|May 29, 2017
PubMed

Insights

Women often underestimate their cardiovascular disease (CVD) risk, especially during reproductive years. Understanding unique female factors is crucial for effective CVD prevention and treatment.

Area of Science:

  • Cardiology
  • Women's Health
  • Preventive Medicine

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality globally.
  • Awareness of CVD risk, diagnosis, and treatment is increasing, yet women remain less informed about their specific risks.
  • Women's unique life stages, including reproductive years and menopause, significantly impact future CVD risk, often overlooked.

Purpose of the Study:

  • To highlight the underrecognized cardiovascular disease (CVD) risks in women.
  • To emphasize the importance of considering female-specific factors in CVD prevention and treatment.
  • To underscore the gender-specific nature of CVD clinical presentation and management.

Main Methods:

  • This study reviews existing literature on cardiovascular disease (CVD) in women.
  • It analyzes the impact of female-specific physiological and lifestyle factors on CVD risk.
  • The review examines gender differences in CVD symptoms, pathogenesis, and treatment responses.

Main Results:

  • Women's CVD risk is significantly influenced by factors unique to their physiology and life stages, such as pregnancy complications and menopause.
  • Oral contraceptives, hormonal imbalances, and psychological factors contribute to CVD risk in women.
  • Gender-specific differences exist in CVD clinical course, symptoms, underlying mechanisms, and responses to medications.

Conclusions:

  • There is a critical need to increase women's awareness of their cardiovascular disease (CVD) risks.
  • Integrating female-specific health considerations into primary and secondary CVD prevention strategies is essential.
  • Recognizing and addressing gender-specific aspects of CVD is vital for optimizing patient outcomes.
Abstract

Related Concept Videos

Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
408
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.8K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
987